Research across Acne vulgaris
Related studies from across the Acne vulgaris family.
38 trials tracked for acne: 28 in phase 3 or 4 and 7 with published results. The most-cited published study has 51 citations.
Showing the 38 most-cited and recently-updated of 38 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Several topical combinations have demonstrated significant efficacy in reducing acne lesions. Adapalene/benzoyl peroxide combination showed a success rate of 47.2% compared to 15.4% (p<0.001) and a 55.5% reduction in total lesion counts (p<0.001) 11. Similarly, clindamycin and benzoyl peroxide combinations resulted in mean reductions of approximately 61-72% for inflammatory lesions and 32-59% for non-inflammatory lesions [17, 19].
Specific topical agents like Epiduo Forte Gel showed significant improvements at week 12, with a 74.2% reduction in inflamed lesions and a 65.4% reduction in non-inflamed lesions, achieving high clinical success rates (p<0.0001) 20. Other treatments such as Tretinoin 21 and ACYC 22 also showed measurable reductions in baseline acne lesions.
IDP-121 Lotion demonstrated statistically significant improvements in both inflammatory and non-inflammatory lesion counts compared to placebo at week 12 (p<0.001) [15, 16]. Dapsone 7.5% gel showed a 74% reduction in inflammatory lesions and a 72% reduction in non-inflammatory lesions by week 16 8.
Systemic treatments included in the evidence include Isotretinoin, which was associated with improvements in acne-specific quality of life scores at week 20 3, and various antibiotics such as Minocycline 9 and Doxycycline 7.
AI synthesis of 8 cited trials, updated Jun 28, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.
Related studies from across the Acne vulgaris family.